Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Fresenius SE & Co. KGaA

Mr. Michael  Sen

CEO, President & Chairman of Management Board of Fresenius Management SE

Ms. Sara Lisa Hennicken

CFO & Member of the Management Board - Fresenius Management SE

Mr. Pierluigi  Antonelli

Member of Management Board of Fresenius Management SE & CEO of Fresenius Kabi

Dr. Michael Sven Moser Ph.D.

Member of Management Board of Fresenius Management SE

Mr. Robert  Moller

Member of the Management Board of Fresenius Management SE

Mr. Nick  Stone

Senior VP of Investor Relations & Head of Investor Relations - Fresenius Management SE

Matthias  Link

Senior Vice President Corporate Communications

Sebastian  Schlagwein

Head of Group ESG

Fresenius SE & Co. KGaA (FRE) Stock Analysis, Discussion Forum and Financial Metrics - XETRA Exchange

FRE's latest dividend is 0.92 EUR on May 18, 2023

FRE Stock Discussion Forum and Message Board

News for XETRA: FRE